Page last updated: 2024-10-25

clofazimine and ER-Negative PR-Negative HER2-Negative Breast Cancer

clofazimine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies

Clofazimine: A fat-soluble riminophenazine dye used for the treatment of leprosy. It has been used investigationally in combination with other antimycobacterial drugs to treat Mycobacterium avium infections in AIDS patients. Clofazimine also has a marked anti-inflammatory effect and is given to control the leprosy reaction, erythema nodosum leprosum. (From AMA Drug Evaluations Annual, 1993, p1619)
clofazimine : 3-Isopropylimino-3,5-dihydro-phenazine in which the hydrogen at position 5 is substituted substituted by a 4-chlorophenyl group, and that at position 2 is substituted by a (4-chlorophenyl)amino group. A dark red crystalline solid, clofazimine is an antimycobacterial and is one of the main drugs used for the treatment of multi-bacillary leprosy. However, it can cause red/brown discolouration of the skin, so other treatments are often preferred in light-skinned patients.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmed, K1
Koval, A1
Xu, J1
Bodmer, A1
Katanaev, VL2
Koval, AV1
Vlasov, P1
Shichkova, P1
Khunderyakova, S1
Markov, Y1
Panchenko, J1
Volodina, A1
Kondrashov, FA1

Other Studies

2 other studies available for clofazimine and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Towards the first targeted therapy for triple-negative breast cancer: Repositioning of clofazimine as a chemotherapy-compatible selective Wnt pathway inhibitor.
    Cancer letters, 2019, 05-01, Volume: 449

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cell

2019
Anti-leprosy drug clofazimine inhibits growth of triple-negative breast cancer cells via inhibition of canonical Wnt signaling.
    Biochemical pharmacology, 2014, Feb-15, Volume: 87, Issue:4

    Topics: Animals; Binding Sites; Cell Line, Tumor; Clofazimine; Crystallography, X-Ray; Growth Inhibitors; HE

2014